Treatment of chronic back pain by sensory discrimination training. A Phase I RCT of a novel device (FairMed) vs. TENS

<p>Abstract</p> <p>Background</p> <p>The causes of chronic low back pain (CLBP) remain obscure and effective treatment of symptoms remains elusive. A mechanism of relieving chronic pain based on the consequences of conflicting unpleasant sensory inputs to the central ne...

Full description

Bibliographic Details
Main Authors: Sackley Catherine M, Elliott Christopher J, Barker Karen L, Fairbank Jeremy CT
Format: Article
Language:English
Published: BMC 2008-06-01
Series:BMC Musculoskeletal Disorders
Online Access:http://www.biomedcentral.com/1471-2474/9/97
id doaj-49acb1c2cd0349748e0d5104493c30f4
record_format Article
spelling doaj-49acb1c2cd0349748e0d5104493c30f42020-11-24T21:44:40ZengBMCBMC Musculoskeletal Disorders1471-24742008-06-01919710.1186/1471-2474-9-97Treatment of chronic back pain by sensory discrimination training. A Phase I RCT of a novel device (FairMed) vs. TENSSackley Catherine MElliott Christopher JBarker Karen LFairbank Jeremy CT<p>Abstract</p> <p>Background</p> <p>The causes of chronic low back pain (CLBP) remain obscure and effective treatment of symptoms remains elusive. A mechanism of relieving chronic pain based on the consequences of conflicting unpleasant sensory inputs to the central nervous system has been hypothesised. As a result a device was generated to deliver sensory discrimination training (FairMed), and this randomised controlled trial compared therapeutic effects with a comparable treatment modality, TENS.</p> <p>Methods</p> <p>60 patients with CLBP were recruited from physiotherapy referrals to a single-blinded, randomised controlled, non-inferiority trial. They were randomised to receive either FairMed or TENS and asked to use the allocated device for 30 minutes, twice a day, for 3 weeks. The primary outcome variable measured at 0 and 3 weeks was pain intensity measured using a visual analogue scale averaged over 7 days. Secondary outcome measures were Oswestry Disability Index, 3 timed physical tests, 4 questionnaires assessing different aspects of emotional coping and a global measure of patient rating of change. Data were analysed for the difference in change of scores between groups using one-way ANOVA.</p> <p>Results</p> <p>Baseline characteristics of the two groups were comparable. The primary outcome, change in pain intensity (VAS) at 3 weeks showed a mean difference between groups of -0.1, (non significant p = 0.82). The mean difference in change in ODI scores was 0.4; (non significant p = 0.85). Differences in change of physical functioning showed that no significant difference in change of scores for any of these test (p = 0.58 – 0.90). Changes in scores of aspects of emotional coping also demonstrated no significant difference in change scores between the groups (p = 0.14 – 0.94).</p> <p>Conclusion</p> <p>FairMed was not inferior to TENS treatment.</p> <p>The findings have implications for further research on current chronic pain theories and treatments. Further work to explore these mechanisms is important to expand our understanding of chronic pain and the role of neuro-modulation.</p> <p>Trial Registration</p> <p>UKCRN Study ID 3321</p> http://www.biomedcentral.com/1471-2474/9/97
collection DOAJ
language English
format Article
sources DOAJ
author Sackley Catherine M
Elliott Christopher J
Barker Karen L
Fairbank Jeremy CT
spellingShingle Sackley Catherine M
Elliott Christopher J
Barker Karen L
Fairbank Jeremy CT
Treatment of chronic back pain by sensory discrimination training. A Phase I RCT of a novel device (FairMed) vs. TENS
BMC Musculoskeletal Disorders
author_facet Sackley Catherine M
Elliott Christopher J
Barker Karen L
Fairbank Jeremy CT
author_sort Sackley Catherine M
title Treatment of chronic back pain by sensory discrimination training. A Phase I RCT of a novel device (FairMed) vs. TENS
title_short Treatment of chronic back pain by sensory discrimination training. A Phase I RCT of a novel device (FairMed) vs. TENS
title_full Treatment of chronic back pain by sensory discrimination training. A Phase I RCT of a novel device (FairMed) vs. TENS
title_fullStr Treatment of chronic back pain by sensory discrimination training. A Phase I RCT of a novel device (FairMed) vs. TENS
title_full_unstemmed Treatment of chronic back pain by sensory discrimination training. A Phase I RCT of a novel device (FairMed) vs. TENS
title_sort treatment of chronic back pain by sensory discrimination training. a phase i rct of a novel device (fairmed) vs. tens
publisher BMC
series BMC Musculoskeletal Disorders
issn 1471-2474
publishDate 2008-06-01
description <p>Abstract</p> <p>Background</p> <p>The causes of chronic low back pain (CLBP) remain obscure and effective treatment of symptoms remains elusive. A mechanism of relieving chronic pain based on the consequences of conflicting unpleasant sensory inputs to the central nervous system has been hypothesised. As a result a device was generated to deliver sensory discrimination training (FairMed), and this randomised controlled trial compared therapeutic effects with a comparable treatment modality, TENS.</p> <p>Methods</p> <p>60 patients with CLBP were recruited from physiotherapy referrals to a single-blinded, randomised controlled, non-inferiority trial. They were randomised to receive either FairMed or TENS and asked to use the allocated device for 30 minutes, twice a day, for 3 weeks. The primary outcome variable measured at 0 and 3 weeks was pain intensity measured using a visual analogue scale averaged over 7 days. Secondary outcome measures were Oswestry Disability Index, 3 timed physical tests, 4 questionnaires assessing different aspects of emotional coping and a global measure of patient rating of change. Data were analysed for the difference in change of scores between groups using one-way ANOVA.</p> <p>Results</p> <p>Baseline characteristics of the two groups were comparable. The primary outcome, change in pain intensity (VAS) at 3 weeks showed a mean difference between groups of -0.1, (non significant p = 0.82). The mean difference in change in ODI scores was 0.4; (non significant p = 0.85). Differences in change of physical functioning showed that no significant difference in change of scores for any of these test (p = 0.58 – 0.90). Changes in scores of aspects of emotional coping also demonstrated no significant difference in change scores between the groups (p = 0.14 – 0.94).</p> <p>Conclusion</p> <p>FairMed was not inferior to TENS treatment.</p> <p>The findings have implications for further research on current chronic pain theories and treatments. Further work to explore these mechanisms is important to expand our understanding of chronic pain and the role of neuro-modulation.</p> <p>Trial Registration</p> <p>UKCRN Study ID 3321</p>
url http://www.biomedcentral.com/1471-2474/9/97
work_keys_str_mv AT sackleycatherinem treatmentofchronicbackpainbysensorydiscriminationtrainingaphaseirctofanoveldevicefairmedvstens
AT elliottchristopherj treatmentofchronicbackpainbysensorydiscriminationtrainingaphaseirctofanoveldevicefairmedvstens
AT barkerkarenl treatmentofchronicbackpainbysensorydiscriminationtrainingaphaseirctofanoveldevicefairmedvstens
AT fairbankjeremyct treatmentofchronicbackpainbysensorydiscriminationtrainingaphaseirctofanoveldevicefairmedvstens
_version_ 1725908639994085376